Clinical Endoscopy

James Edward Dixon

1 Article

The Outcome of Endoscopic Radiofrequency Anti-Reflux Therapy (STRETTA) for Gastroesophageal Reflux Disease in Patients with Previous Gastric Surgery: A Prospective Cohort Study: Edward John Nevins, James Edward Dixon, Yirupaiahgari Krishnaiah Setty Viswanath; Clin Endosc 2021;54(4):542-547. Published online March 24, 2021; DOI: https://doi.org/10.5946/ce.2020.243

Background
/Aims: STRETTA improves the quality of life and reduces the need for anti-reflux medication in select patients, especially those with uncomplicated gastroesophageal reflux disease (GERD). We aimed to review the outcomes of STRETTA in patients with medically refractory GERD, who had undergone previous gastric surgery.
Methods
This was a review of a prospective database in a British center. Since 2016, all GERD patients who underwent STRETTA and had a history of previous gastric surgery were studied (n=11). Anti-reflux medication pre- and post-STRETTA was evaluated. The outcomes were assessed objectively by the change in anti-reflux medication and subjectively through a pre- and post-procedure GERD-health-related quality of life (HRQL) questionnaire.
Results
The median length of follow-up was 23 months. Nine patients demonstrated improved GERD-HRQL scores following STRETTA (82%). Of the 7 patients who underwent fundoplication, all reported improved symptoms, with 3 patients discontinuing the medication and 3 patients on a reduced dose of proton pump inhibitor. Four patients underwent surgery other than fundoplication, of which 2 reported improvement and discontinued the proton pump inhibitor. Two patients reported no improvement.
Conclusions
This study demonstrates that STRETTA is successful in reducing refractory GERD in patients with previous gastric surgery. The outcomes were comparable to published outcomes in patients with uncomplicated GERD with no previous history of gastric surgery.

Citations

Citations to this article as recorded by

The Need for Updated Classification of Esophageal Motility Disorders Using High-resolution Impedance Manometry
Sung Eun Kim
Journal of Neurogastroenterology and Motility.2024; 30(1): 1. CrossRef
Endoscopic radiofrequency Stretta therapy reduces proton pump inhibitor dependency and the need for anti-reflux surgery for refractory gastroesophageal reflux disease
Abraham Joel, Alakh Konjengbam, Yirupaiahgari Viswanath, Georgios Kourounis, Emily Hammond, Helen Frank, Shivani Kuttuva, Simon Mbarushimana, Hena Hidayat, Srivishnu Thulasiraman
Clinical Endoscopy.2024; 57(1): 58. CrossRef
Long-term efficacy of endoscopic radiofrequency Stretta therapy for patients with refractory gastroesophageal reflux disease
Sung Eun Kim
Clinical Endoscopy.2024; 57(1): 48. CrossRef
Endoscopic Non-ablative Radiofrequency Treatment (Stretta) for Gastroesophageal Reflux Disease (GERD)
George Triadafilopoulos
Current Gastroenterology Reports.2024; 26(4): 93. CrossRef
Endoscopic Management Options for Gastroesophageal Reflux Disease
Bhavana Sreepad, Karteek Chennupati, Muhammad Shehroz Zeeshan, Zeeshan Ramzan
Cureus.2024;[Epub] CrossRef
Chinese expert consensus on radiofrequency therapy for gastroesophageal reflux disease 2024
Xinke Sui, Zhiwei Hu, Jimin Wu, Lianyong Li
Gastroenterology & Endoscopy.2024; 2(3): 141. CrossRef
In Which Situation is Endoscopic Radiofrequency Anti-Reflux Therapy (Stretta) Effective for Controlling Gastroesophageal Reflux Symptoms?
Hwoon-Yong Jung
Clinical Endoscopy.2021; 54(4): 451. CrossRef
Endoscopic Treatment of GERD in Patients With Obesity
Rabih Ghazi, Babusai Rapaka, Barham K. Abu Dayyeh
Foregut: The Journal of the American Foregut Society.2021; 1(4): 336. CrossRef

5,095 View
135 Download
4 Web of Science
8 Crossref

Author index